Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
DiaMedica Therapeutics
DMAC
$376M
| $141K | ﹤0.01% |
+33,690
| New | +$141K |
|
3677
SAB Biotherapeutics
SABS
$22.1M
| $140K | ﹤0.01% |
51,946
-838
| -2% | -$2.26K |
|
3678
Carisma Therapeutics
CARM
$15.8M
| $140K | ﹤0.01% |
142,522
-17,519
| -11% | -$17.2K |
|
3679
Innovative Solutions & Support
ISSC
$199M
| $140K | ﹤0.01% |
21,440
-9,890
| -32% | -$64.5K |
|
|
ARMN
3680
Aris Mining
ARMN
$1.97B
| $139K | ﹤0.01% |
30,125
-239,512
| -89% | -$1.11M |
|
3681
Sensus Healthcare
SRTS
$53.3M
| $139K | ﹤0.01% |
23,926
-26,018
| -52% | -$151K |
|
|
KGEI
3682
Kolibri Global Energy
KGEI
$192M
| $137K | ﹤0.01% |
42,857
-1,886
| -4% | -$6.04K |
|
|
SEG.RT
3683
DELISTED
Seaport Entertainment Group Inc. Rights (expiring October 10, 2024)
SEG.RT
| $137K | ﹤0.01% |
+46,309
| New | +$137K |
|
3684
Gran Tierra Energy
GTE
$139M
| $136K | ﹤0.01% |
+21,745
| New | +$136K |
|
3685
Inspired Entertainment
INSE
$255M
| $134K | ﹤0.01% |
14,426
+164
| +1% | +$1.52K |
|
3686
Quantum-Si Incorporated
QSI
$243M
| $133K | ﹤0.01% |
150,865
-223,862
| -60% | -$197K |
|
3687
Meridian
MRBK
$175M
| $129K | ﹤0.01% |
10,240
-680
| -6% | -$8.6K |
|
3688
Serina Therapeutics
SER
$52.3M
| $129K | ﹤0.01% |
19,256
-2,416
| -11% | -$16.2K |
|
3689
Gulf Island Fabrication
GIFI
$123M
| $128K | ﹤0.01% |
22,643
-17,613
| -44% | -$99.3K |
|
3690
PureCycle Technologies
PCT
$2.4B
| $127K | ﹤0.01% |
+13,344
| New | +$127K |
|
3691
Polen Capital Global Growth ETF
PCGG
$192M
| $125K | ﹤0.01% |
+10,896
| New | +$125K |
|
|
OCEA
3692
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $125K | ﹤0.01% |
127,562
-40,571
| -24% | -$39.8K |
|
3693
C4 Therapeutics
CCCC
$194M
| $125K | ﹤0.01% |
21,848
-487,558
| -96% | -$2.78M |
|
|
CLPR
3694
Clipper Realty
CLPR
$70.6M
| $121K | ﹤0.01% |
21,275
+4,638
| +28% | +$26.4K |
|
|
MESO
3695
Mesoblast
MESO
$1.97B
| $120K | ﹤0.01% |
14,664
+1,189
| +9% | +$9.71K |
|
|
EFXT
3696
Enerflex
EFXT
$1.28B
| $119K | ﹤0.01% |
19,922
-74,687
| -79% | -$445K |
|
3697
PepGen
PEPG
$44.3M
| $118K | ﹤0.01% |
+13,822
| New | +$118K |
|
|
PFO
3698
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$126M
| $118K | ﹤0.01% |
12,552
| – | – |
|
3699
OPAL Fuels
OPAL
$64.4M
| $117K | ﹤0.01% |
32,173
-50,361
| -61% | -$184K |
|
3700
Clearside Biomedical
CLSD
$27.4M
| $116K | ﹤0.01% |
91,019
+48,130
| +112% | +$61.1K |
|